Dr. Steven Craig of the University of Wollongong presented data on the molecular subgroups identified by Thyroid GuidePx™ at the 90th Annual Meeting of the American Thyroid Association. The presentation at the virtual meeting, entitled “Molecular Subgroups Identified by Machine Learning Enable Accurate Prognostication of Papillary Thyroid Cancer” was well received and generated significant interest. Dr. Craig, an endocrine surgeon and surgical oncologist from Australia, spoke of the potential clinical utility of the molecular test. “This molecular test is a major advancement in precision medicine for thyroid cancer patients. It could completely change the way we treat thyroid cancer by providing accurate prognostic information prior to surgery, and better personalize therapeutic options for any individual,” said Dr Craig.
Introducing Thyroid GuidePx®